NCT05586516 2025-03-20A Study to Assess an ATX Inhibitor (IOA-289) in Patients with Metastatic Pancreatic CanceriOncturaPhase 1/2 Active not recruiting24 enrolled
NCT06119217 2024-12-04Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC PatientsTrishula Therapeutics, Inc.Phase 2 Active not recruiting194 enrolled
NCT03678883 2024-11-079-ING-41 in Patients with Advanced CancersActuate Therapeutics Inc.Phase 2 Active not recruiting350 enrolled